Figure 2

FAS-AS1 was downregulated in NPC and correlated with prognosis of various cancers. (a) The gene expression profile of FAS-AS1 across all tumor samples and paired normal tissues. Each dots represent expression of samples. (b) Relative expression of FAS-AS1 in NPC tissues and rhinitis tissues were examined by RT-qPCR. (c) The expression level of FAS-AS1 was associated with clinical stage of NPC patients. (d) The expression level of FAS-AS1 was associated with short-term treatment efficacy of NPC patients. (e) Relative expression of FAS in NPC tissues and rhinitis tissues were examined by RT-qPCR. (f) The expression level of FAS was associated with clinical stage of NPC patients. (g) The expression level of FAS was not associated with short-term treatment efficacy of NPC patients. (h) Correlation analysis of FAS-AS1 and FAS in NPC tissues. (i–l) FAS-AS1 was associated with survival in breast cancer (i), ovarian cancer (j), lung cancer (k), and gastric cancer (l). *P < 0.05, **P < 0.01.